Application of OrVil TM in patients with recurrent or denovo esophagogastric junction cancer
10.3760/cma.j.cn113855-20220902-00544
- VernacularTitle:经口置入钉砧头系统在食管胃结合部癌复发及再发癌患者手术中的应用
- Author:
Junli ZHANG
1
;
Chenyu LIU
;
Sen LI
;
Yanghui CAO
;
Pengfei MA
;
Xijie ZHANG
;
Zhenyu LI
;
Changzheng LI
;
Yuzhou ZHAO
Author Information
1. 郑州大学附属肿瘤医院(河南省肿瘤医院)普外科，郑州 450000
- Keywords:
Stomach neoplasms;
Esophagogastric junction;
Neoplasm recurrence, local
- From:
Chinese Journal of General Surgery
2023;38(4):258-262
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effect of transorally inserted anvil (OrVil TM) in patients with relapsed or denovo carcinoma at the esophagogastric junction. Methods:The clinical data of 60 patients who underwent radical intent resection for locally relapsed or denovo esophagogastric junction adenocarcinoma at Zhengzhou University Cancer Hospital from Jan 2011 to Jun 2021 were retrospectively analyzed. The patients were divided into two groups according to whether transorally inserted anvil was used. Twenty-six patients who had used the system were assigned to the experimental group. Thirty-four patients without transorally inserted anvil were set to control group.Results:The incisor distance of the experimental group was shorter than that of the control group [36(34-40)cm vs. 39(36-41)cm, Z=-4.948, P<0.05]. Operation time in experimental group was 177 (145-260) min, compared to control group of 172 (140-225) min ( Z=-0.735, P=0.463). Intraoperative blood loss was 200 (100-900) ml in the experimental group and 300 (100-800) ml in the control group ( Z=-1.244, P=0.213). Postoperative upper margin distance of the experimental group was (3.6±1.7) cm compared to control group of (1.8±1.1) cm ( t=-0.735, P<0.01). The positive rate of margin in the experimental group was 4% vs. 15% in the control group ( χ2=1.931, P=0.165). The length of postoperative hospital stay in the experimental group was (18.6±5.2) d vs. (20.5±4.7) d ( t=-1.455, P=0.151). Surgery-related complications developed in 19% in the experimental group vs. 27% in the control group ( P>0.05). Conclusion:The application of the transorally inserted anvil in the operation of patients with locally relapsed or denovo esophagogastric junction cancer after initial operation reduces the difficulty of operation and decreases the positive rate of margin.
